Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001056520-13-000096
Filing Date
2013-04-12
Accepted
2013-04-12 17:26:00
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10K cellcyte201210kfinal.htm 10-K 575752
2 CODE OF ETHICS codeofethicsandinsidertradin.htm EX-14 31322
3 CERTIFICATION exhibit31123112.htm EX-31 15121
4 CERTIFICATION exhibit32123112.htm EX-32 5258
  Complete submission text file 0001056520-13-000096.txt   2220400

Data Files

Seq Description Document Type Size
5 INSTANCE ccyg-20121231.xml EX-101.INS 247483
6 SCHEMA ccyg-20121231.xsd EX-101.SCH 7486
7 CALCULATION ccyg-20121231_cal.xml EX-101.CAL 4834
8 DEFINITION ccyg-20121231_def.xml EX-101.DEF 9954
9 LABEL ccyg-20121231_lab.xml EX-101.LAB 116541
10 PRESENTATION ccyg-20121231_pre.xml EX-101.PRE 86118
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52238 | Film No.: 13759451
SIC: 2834 Pharmaceutical Preparations